PDS Biotechnology Corp. (PDSB)
0.6251
-0.02
(-3.77%)
USD |
NASDAQ |
Mar 19, 16:00
0.6145
-0.01
(-1.70%)
After-Hours: 20:00
PDS Biotechnology EPS Diluted (Quarterly) : -0.1922 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.009M |
| Total Expenses (Quarterly) | 9.009M |
| Enterprise Value | 25.97M |
| Earnings Yield | -130.8% |
| Normalized Earnings Yield | -130.80 |